Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $527.90 ($5.1M) on 2026-10-06, disclosed to the SEC on 2026-10-07.
Scheduled sale ($5.1M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $527.90 | 280 | $148K | 2.9% |
| 2 | $528.72 | 360 | $190K | 3.7% |
| 3 | $530.13 | 240 | $127K | 2.5% |
| 4 | $531.94 | 320 | $170K | 3.3% |
| 5 | $533.14 | 215 | $115K | 2.2% |
| 6 | $534.30 | 167 |
| $89K |
| 1.7% |
| 7 | $535.71 | 734 | $393K | 7.7% |
| 8 | $536.25 | 323 | $173K | 3.4% |
| 9 | $537.58 | 133 | $71K | 1.4% |
| 10 | $538.61 | 1,088 | $586K | 11.5% |
| 11 | $539.68 | 1,606 | $867K | 16.9% |
| 12 | $540.68 | 2,054 | $1.1M | 21.7% |
| 13 | $541.55 | 380 | $206K | 4.0% |
| 14 | $542.49 | 120 | $65K | 1.3% |
| 15 | $543.99 | 558 | $304K | 5.9% |
| 16 | $544.75 | 842 | $459K | 9.0% |
| 17 | $545.50 | 80 | $44K | 0.9% |
| Total | $538.67 avg | 9,500 | $5.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |